Company Filing History:
Years Active: 2012
Title: Innovator Profile: Yan-Wei Li
Introduction: Yan-Wei Li is a notable inventor based in Hsinchu, Taiwan, recognized for his contributions to the pharmaceutical industry. His innovative work focuses on developing efficient methods for synthesizing complex chemical compounds, showcasing his expertise in medicinal chemistry.
Latest Patents: Yan-Wei Li holds a patent for a novel approach to preparing atomoxetine, a drug used in the treatment of attention deficit hyperactivity disorder (ADHD). The patent presents an efficient method that yields high quantities of atomoxetine without the need for resolution processes, employing (R)-methylhydroxylaminopropanol as an intermediate. This significant advance not only enhances production efficiency but also paves the way for improved accessibility of this important medication.
Career Highlights: Yan-Wei Li is currently affiliated with Sci Pharmtech Inc., where he applies his extensive knowledge in pharmaceutical sciences. His groundbreaking research contributes to the company’s mission of innovating and enhancing drug development processes.
Collaborations: Throughout his career, Yan-Wei has collaborated with distinguished colleagues, such as Bo-Fong Chen and Jinun-Ban Yeh. These partnerships highlight the collaborative spirit of innovation and the sharing of ideas that are essential in the field of scientific research.
Conclusion: With a focus on innovative methodologies in drug synthesis, Yan-Wei Li continues to make strides within the pharmaceutical sector. His patent for the preparation of atomoxetine exemplifies his dedication to improving drug production, while his work at Sci Pharmtech Inc. positions him as a key player in the ongoing advancement of medicinal chemistry. As the landscape of drug development evolves, inventors like Yan-Wei Li are at the forefront, pushing boundaries and setting new standards in the industry.